Skip to NavigationSkip to content

Pharmafile - Business Services News

Patient centricity, derived from the NHS-driven thinking “no decision about me, without me,” has been adopted by pharma to understand their patients...
President Donald Trump has caused confusion as to whether or not the NHS will ‘be on the table’ in post-Brexit trade deal negotiations with the...
FDA approves new tests for chlamydia and gonorrhoea; Drugmakers colluded to drive up price of anti-nausea drug by 700%; Pharma firms paid Italian...
Novo Holdings has agreed to buy 10.1% of shares in British firm Oxford Biomedica for £53.5 million.
New positive data for Janssen's esketamine depression treatment, MSD buys Peloton Therapeutics for $2.1 billion, and Gilead CEO grilled on why its...
Four pharmaceutical firms have been accused of illegally colluding to restrict the supply of anti-nausea medication Prochlorperazine after the...
Japan’s Health Ministry has warned that Eli Lilly’s breast cancer therapy Verzenio could have serious side effects for patient’s lungs.
Gilead, Janssen and BMS accused of forging anticompetitive deal; Novartis buy Takeda's dry eye drug Xiidra for $5.3 billion; NHS England to pay for...
Shares in ImmunoGen fell 32% in premarket trading after the firm said the FDA had recommended a new Phase 3 trial of its ovarian cancer drug...
Eli Lilly's Emgality shows positive Phase 3 results in treatment of migraine as Lundbeck acquire Abide Therapeutics in deal worth $400 million....
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches